This inventor holds 2 USPTO granted patents. Top assignees: Biotest Ag, Biotest Gmbh & Co. Kgaa. Active years: 2022-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022-2026
Title: Alexander Moehlenkamp-Roettger: Innovator in Immunoglobulin Composition
Introduction
Alexander Moehlenkamp-Roettger is a notable inventor based in Floersheim-Wicker, Germany. He has made significant contributions to the field of immunology through his innovative processes for preparing immunoglobulin compositions. His work is particularly relevant in the pharmaceutical industry, where the demand for effective immunoglobulin therapies continues to grow.
Latest Patents
Moehlenkamp-Roettger holds a patent for a "Process for preparing immunoglobulin compositions." This patent describes a method for creating pharmaceutically acceptable immunoglobulin compositions from plasma-derived immunoglobulin fractions. The process allows for the parallel preparation of immunoglobulin compositions that are enriched in IgG, IgM, and IgA. Specifically, it involves resolubilizing immunoglobulin contained in Cohn fraction I/II/III or Kistler Nitschmann fraction A+I at conductivities of at least 1 mS/cm. After removing contaminating proteins, the resolubilized immunoglobulin undergoes anion exchange chromatography to obtain the desired enriched compositions. Furthermore, the IgG-enriched immunoglobulin composition is treated with a cation exchange material to reduce properdin content.
Career Highlights
Moehlenkamp-Roettger is associated with Biotest AG, a company that specializes in the development and production of immunological products. His work at Biotest AG has allowed him to focus on advancing immunoglobulin therapies, contributing to the company's reputation in the pharmaceutical sector.
Collaborations
He has collaborated with notable colleagues, including Oliver Maneg and Achim Hannappel. These collaborations have likely enhanced the research and development efforts within the company, fostering innovation in immunoglobulin therapies.
Conclusion
Alexander Moehlenkamp-Roettger is a distinguished inventor whose work in immunoglobulin composition preparation has the potential to impact the pharmaceutical industry significantly. His innovative processes and collaborations continue to drive advancements in immunology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile